Evidence map›Paper›PMID 41126658›Full record

ReviewGenome biology and evolution2025

HJ Muller and the Relationship Between Sex Chromosome Degeneration and the Evolution of Dosage Compensation.

Brian Charlesworth, Deborah Charlesworth

Abstract readReview
In one paragraph

Review in Genome biology and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brian CharlesworthInstitute of Ecology and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0002-2706-355X
Deborah CharlesworthInstitute of Ecology and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0002-3939-9122

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A lack of recombination in the heterogametic sex between parts or all of newly evolving sex chromosomes results in the gradual accumulation of deleterious mutations on proto-Y or proto-W chromosomes. This "genetic degeneration" is caused by several population genetic mechanisms. It can eventually lead to the loss of functionality and deletions of Y- or W-linked genes in species with male or female heterogamety, respectively, reducing the fitness of heterozygous XY males or ZW females. This creates selection to compensate for such degeneration. Contemporary studies of degeneration and dosage compensation are built on classical genetic work by HJ Muller, with molecular analyses of genomes and gene expression now revealing new details. We review these studies, integrating ideas about how degeneration and compensation evolve. We discuss whether these two processes evolve together, whether the initial changes involved in compensation occurred in individual sex-linked genes ("piecemeal"), and whether they were sex specific. We also discuss the idea that control of expression across larger chromosome regions reflects later changes, after increased expression of X- or Z-linked genes in both sexes favored reduced X expression in females (or Z expression in males with female heterogamety). We summarize the currently available empirical evidence and discuss difficulties involved in documenting the evolutionary changes that lead to the different types of dosage compensation, as well as limitations of the data for testing evolutionary hypotheses.

Indexed as

Dosage Compensation, GeneticEvolution, MolecularSex ChromosomesAnimalsFemaleHumansMaledeleterious mutationsdominancedosage sensitivitygene expressionHill–Robertson interferenceregulatory evolution

Identifiers

PMID41126658
PMCPMC12598394

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.